# Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

> **NCT00942357** · PHASE3 · UNKNOWN · sponsor: **Gynecologic Oncology Group** · enrollment: 813 (actual)

## Conditions studied

- Endometrial Clear Cell Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Stage IA Uterine Corpus Cancer AJCC v7
- Stage IB Uterine Corpus Cancer AJCC v7
- Stage II Uterine Corpus Cancer AJCC v7
- Stage IIIA Uterine Corpus Cancer AJCC v7
- Stage IIIB Uterine Corpus Cancer AJCC v7
- Stage IIIC Uterine Corpus Cancer AJCC v7
- Stage IVA Uterine Corpus Cancer AJCC v7

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Cisplatin
- **RADIATION:** Internal Radiation Therapy
- **DRUG:** Paclitaxel
- **OTHER:** Quality-of-Life Assessment
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00942357
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06-29
- **Primary completion:** 2016-02-15
- **Final completion:** 2024-07-28
- **Target enrollment:** 813 (ACTUAL)
- **Last updated:** 2021-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942357, "Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00942357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*